Dr. Alexeeva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
95 Madison Ave
Ste 306
Morristown, NJ 07960Phone+1 973-695-8033Fax+1 973-538-0043
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2019 - 2022
- Northwestern Feinberg School of MedicineMD, 2014 - 2018
- Northwestern University The Feinberg School of MedicineClass of 2018
Certifications & Licensure
- CA State Medical License 2019 - 2025
- NJ State Medical License 2024 - 2025
- IL State Medical License 2018 - 2019
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
Publications & Presentations
PubMed
- 177 citationsOnce-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II studySimon Travis, Silvio Danese, Limas Kupčinskas, Olga Alexeeva, Geert D'Haens
Gut. 2014-03-01 - 185 citationsOmega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.Brian G. Feagan, William J. Sandborn, Ulrich Mittmann, S. Bar-Meir, Geert R. D'Haens
JAMA. 2008-04-09 - 132 citationsEfficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase...Byong Duk Ye, Marina Pesegova, Olga Alexeeva, Marina Osipenko, Adi Lahat
Lancet. 2019-04-27
Journal Articles
- Electronic Clinical Decision Support Tools for Obesity and Gastroesophageal Reflux Disease: The Provider’s PerspectiveDavid Liebovitz, John E Pandolfino, Olga Alexeeva, Rajesh N Keswani, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: